Petros Pharmaceuticals Inc (PTPI)
$0.37 $0.02 (6.02%) 12:13 PM 12/11/24
NASDAQ | $USD | Drug Manufacturers - Specialty & GenericStock Data
-
Market Cap
$3.35M -
Day's Range
$0.35 - $0.37 -
Volume
247,052 -
52 Week Low / High
$0.22 - $2.27 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
PTPI's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 0
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $4.00
- Target Price
Company News
-
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says — Jun 17th, 2024
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says Petros Pharmaceuticals Inc (NASDAQ:PTPI) is a pharmaceutical company focusing on men’s health therapeutics. In an interview with Benzinga, Fady Bocto...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$